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Abstract
Atrial natriuretic peptide (ANP) provides a potent defense mechanism against volume overload in mammals. Its primary
receptor, natriuretic peptide receptor-A (NPR-A), is localized mostly in the kidney, but also is found in hypothalamic areas
involved in body fluid volume regulation. Acute glucocorticoid administration produces potent diuresis and natriuresis,
possibly by acting in the renal natriuretic peptide system. However, chronic glucocorticoid administration attenuates renal
water and sodium excretion. The precise mechanism underlying this paradoxical phenomenon is unclear. We assume that
chronic glucocorticoid administration may activate natriuretic peptide system in hypothalamus, and cause volume
depletion by inhibiting dehydration-induced water intake. Volume depletion, in turn, compromises renal water excretion. To
test this postulation, we determined the effect of dexamethasone on dehydration-induced water intake and assessed the
expression of NPR-A in the hypothalamus. The rats were deprived of water for 24 hours to have dehydrated status. Prior to
free access to water, the water-deprived rats were pretreated with dexamethasone or vehicle. Urinary volume and water
intake were monitored. We found that dexamethasone pretreatment not only produced potent diuresis, but dramatically
inhibited the dehydration-induced water intake. Western blotting analysis showed the expression of NPR-A in the
hypothalamus was dramatically upregulated by dexamethasone. Consequently, cyclic guanosine monophosphate (the
second messenger for the ANP) content in the hypothalamus was remarkably increased. The inhibitory effect of
dexamethasone on water intake presented in a time- and dose-dependent manner, which emerged at least after 18-hour
dexamethasone pretreatment. This effect was glucocorticoid receptor (GR) mediated and was abolished by GR antagonist
RU486. These results indicated a possible physiologic role for glucocorticoids in the hypothalamic control of water intake
and revealed that the glucocorticoids can act centrally, as well as peripherally, to assist in the normalization of extracellular
fluid volume.
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Introduction
Atrial natriuretic peptide (ANP), a peptide hormone secreted by
the heart in response to volume expansion, revealed a homeostatic
mechanism that counterbalanced the salt- and water-retaining
actions of the renin–angiotensin–aldosterone system that predom-
inates in terrestrial animals. The primary receptor of ANP,
natriuretic peptide receptor-A (NPR-A) is localized mostly in the
kidney, but also is found in hypothalamic area involved in body
fluid volume regulation [1,2,3]. Renal NPR-A activation induces
potent diuresis and natriuresis, whereas hypothalamic NPR-A
activation inhibits dehydration-induced water intake [4,5]. Previ-
ous evidences showed that glucocorticoids could upregulate ANP
mRNA expression in the atrial myocytes and increase the ANP
levels in the circulation [6,7,8]. Recent evidences further showed
that glucocorticoids could upregulate NPR-A expression in the
kidney [9]. It is postulated that acute glucocorticoid administration
produces potent diuresis and natriuresis, possibly acting in the
natriuretic peptide system in the kidney [6,7,8,9,10]. However, it
cannot account for the fact that chronic glucocorticoid adminis-
tration attenuates renal water and sodium excretion in intact rats
[11,12]. The precise mechanism underlying these paradoxical
finding is unclear. Thus, we raised a hypothesis that chronic
glucocorticoid administration may activate natriuretic peptide
system in hypothalamus, and cause volume depletion by inhibiting
dehydration-induced water intake. Volume depletion, in turn,
compromises renal water and sodium excretion. To test the
hypothesis, we carried out this study.
Results
The effect of 6-hour Dex pretreatment on urinary volume
and water intake
Thirty male Wistar rats were deprived of water for 24 hours to
have dehydration status. Then, tap water was given, and water
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were randomized to receive vehicle, low dose of dexamethasone
sodium phosphate (Dex, 0.1 mg/kg) or high dose of Dex (1.0 mg/
kg) 6 hours prior to free access to water.
In the 6-hour pretreatment period, Dex pretreatment doubled
renal water excretion in the water-deprived rats (Fig. 1A). But, 6-hour
Dex pretreatment did not affect subsequent dehydration-induced
water intake over 12-hour water-access period (Fig. 1B). Of note,
Dex-pretreated rats produced a potent, dose-dependent diuresis
during 12-hour water-access period (Fig. 1C). In view of the fact that
glucocorticoids produced potent diuresis without affecting water
intake, relative volume depletion, inevitably, occurred.
The effect of 18-hour Dex pretreatment on urinary
volume and water intake
The 24-hour water-deprived rats were randomized to receive
vehicle, low dose of Dex or high dose of Dex 18 hours prior to free
access to water.
During the 18-hour pretreatment period, Dex pretreatment
doubled renal water excretion in the water-deprived rats (Fig. 2A).
The 18-hour Dex pretreatment dramatically inhibited the
dehydration-induced water intake over 12-hour water-access
period, but there was no difference in water intake between two
Dex-pretreated groups (Fig. 2B). Even though, the water-deprived
rats pretreated with large dose of Dex produced a remarkable
diuresis in 12-hour water-access period (Fig. 2C).
The effect of 24-hour Dex pretreatment on urinary
volume and water intake
As pretreatment prolonged to 24 hours, the water intake in rats
treated with large dose of Dex was dramatically decreased
compared with the water intake in the rats pretreated with vehicle
or low dose of Dex. The rats pretreated with low dose of Dex
drank less water compared with vehicle pretreated rats, but there
was no statistical difference in water intake between two groups
(Fig. 3B). There was a slight, but not a statistically significant,
reduction in urinary volume in the rats pretreated with large dose
of Dex (Fig. 3C).
Collectively, Dex not only produced a potent diuresis but
inhibited dehydration-induced water intake. The effect was both
Figure 1. The effect of 6-hour Dex pretreatment on urinary volume and water intake. [A] Effect of Dex pretreatment on urinary volume
during 6-hour pretreatment period; *,0.01 compared with rats treated with vehicle. [B] Effect of Dex pretreatment on cumulative water intake
during water-access period in the dehydrated rats; n=10 for each group; data were analyzed by two-way repeated measures ANOVA. [C] Effect of
Dex pretreatment on urinary volume during water-access period; *,0.01 compared with rats treated with vehicle; # ,0.01 compared with rats
treated with low dose of Dex.
doi:10.1371/journal.pone.0015607.g001
Figure 2. The effect of 18-hour Dex pretreatment on urinary volume and water intake. [A] Effect of Dex pretreatment on urinary volume
during 18-hour pretreatment period; *,0.01 compared with rats treated with vehicle. [B] Effect of Dex pretreatment on cumulative water intake
during water-access period in the dehydrated rats; n=10 for each group; data were analyzed by two-way repeated measures ANOVA; *,0.01
compared with rats treated with vehicle. [C] Effect of Dex pretreatment on urinary volume during water-access period; *,0.01 compared with rats
treated with vehicle; # ,0.01 compared with rats treated with low dose of Dex.
doi:10.1371/journal.pone.0015607.g002
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glucocorticoids on drinking emerges, the diuretic effects of
glucocorticoids were attenuated.
The effect of Dex on hypothalamic NPR-A expression and
cGMP content
Earlier observations showed that infusion of ANP into the third
cerebral ventricle of conscious rats inhibited dehydration- or
angiotensin II (AII)-induced water intake, and salt depletion-
induced salt appetite in conscious rats, supporting an important
role of natriuretic peptide system in the central control of
extracellular fluid volume and electrolyte composition [1,13].
To determine the effect of Dex on hypothalamic NPR-A
expression, we assessed its expression using western blotting
analysis. It showed that 24-hour Dex pretreatment remarkably
increased hypothalamic NPR-A expression in the water-deprived
rats, compared with vehicle pretreatment. However, there was no
statistical difference in hypothalamic NPR-A expression between
Dex-pretreated rats (Fig. 4A, B). Consistent with the western
blotting analysis, NPR-A positive neurons in the hypothalamus
visualized by immunofluorescence were dramatically increased by
Dex (Fig. 4D, E).
Hypothalamic cyclic guanosine monophosphate (cGMP, the
second messenger for the ANP) content serves as a useful
biological marker for the activity of NPR-A in vivo. There was a
dramatic increase in hypothalamic cGMP content in the Dex-
pretreated rats. However, the hypothalamic cGMP content in the
rats pretreated with high dose of Dex was slightly, but not
statistically significantly, higher than that in rats pretreated with
low dose of Dex for 24 hours (Fig. 4C).
The water-deprived rats pretreated with large dose of Dex but
not low dose of Dex had a slightly, but nevertheless, statistically
higher ANP levels than that in vehicle pretreated rats both in 6- and
24-hour Dex pretreated rats (Fig. 5A, B). However, the change in
ANP levels was quantitively smaller, which cannot account for the
inhibitory effect on water intake induced by Dex. In addition, Dex
had no effect on ANP levels in the hypothalamus (Fig. 5C), which
was consistent with previous findings [14,15,16]. Therefore, the
upregulation of hypothalamic NPR-A expression by Dex could
contribute to the NPR-A activation in the hypothalamus.
Reversal of the effects of Dex on body fluid control by
RU486
With the use of RU486, it is possible to block the glucocorticoid
receptor (GR) mediated effects in experimental animals. To
examine directly whether the effects of Dex on body fluid control
were GR mediated, we used RU486 to determine if the effects of
Dex on body fluid control were depended on activation of the GR.
RU486 at a dose of 100 mg/kg completely reversed the effect of
24-hour Dex pretreatment on urinary excretion and water intake,
and RU486 alone did not affect water intake and diuresis (Fig. 6A,
B) in water-deprived rats. RU486 also prevented Dex-induced
changes in NPR-A expression and cGMP levels in the hypothal-
amus (Fig. 6C, D, E).The antagonism of the effects of Dex by
RU486 at 100 times concentration is consistent with previous
results demonstrating RU486 inhibition of known GR receptor-
mediated effects [17,18,19].
Anti-hANP antiserum (North Institute of Biological Technolo-
gy, Beijing), which can neutralize endogenous ANP, was
administrated intracerebroventricularly to inhibit the activation
of hypothalamic NPR-A. Pretreatment with 2 mL anti-hANP
antiserum (1:10 dilution) was administrated intracerebroventricu-
larly and blocked the inhibitory effect of glucocorticoids on water
intake (Fig. 6F), which was consistent with previous findings that
anti-ANP antiserum could potentiate dehydration or angiotensin
II induced water intake in the rat [20,21].
Potent volume-depleting effect by Dex in rats given ad
libitum access to food and water
Thirty Wistar rats given ad libitum access to food and water
were randomized to receive low dose of Dex (0.1 mg/kg), large
dose of Dex (1 mg/kg) or vehicle. We monitored urinary volume,
urinary sodium, water intake, food intake and body weight for
24 hours. Acute systemic glucocorticoid administration induced a
potent renal water and sodium excretion (Fig. 7A, B). Of note,
water intake and food intake remained the same between all three
groups despite of the potent diuresis in Dex group (Fig. 7C, D),
which led to a dramatic body weight reduction (i.e. systemic
volume depletion) in the rats (Fig. 7E). Dex-treated animals did not
drink more water than controls despite having much higher urine
volumes.
Figure 3. The effect of 24-hour Dex pretreatment on urinary volume and water intake. [A] Effect of Dex pretreatment on urinary volume
during 24-hour pretreatment period; *,0.01 compared with rats treated with vehicle. [B] Effect of Dex pretreatment on cumulative water intake
during water-access period in the dehydrated rats; n=10 for each group; data were analyzed by two-way repeated measures ANOVA; *,0.01
compared with rats treated with vehicle; # ,0.01 compared with rats treated with low dose of Dex. [C] Effect of Dex pretreatment on urinary volume
during water-access period.
doi:10.1371/journal.pone.0015607.g003
Glucocorticoids and Thirst
PLoS ONE | www.plosone.org 3 December 2010 | Volume 5 | Issue 12 | e15607Glucocorticoids and Thirst
PLoS ONE | www.plosone.org 4 December 2010 | Volume 5 | Issue 12 | e15607Discussion
Studies of glucocorticoids in body fluid metabolism have yielded
conflicting results, which may reflect differences in dosage
regimens, the time of treatment, or the specific body fluid volume
status. The present study showed that glucocorticoids dramatically
increased NPR-A density in the hypothalamus and an associated
inhibitory effect on dehydration-induced water intake.
Many publications documented a paradoxical phenomenon
that acute and chronic administration of glucocorticoid has
different effects on renal water and sodium excretion. Acute
administration of glucocorticoids produces diuresis and natriuresis,
an effect more clearly demonstrable during the first 12 hours of
administration, while chronic administration of the glucocorticoid
attenuates renal water and sodium excretion [11,12]. Our findings
provided a clear answer for this phenomenon. Glucocorticoids
increase renal and hypothalamic NPR-A density. Thus, they can
produce potent diuretic effects and centrally inhibit water intake at
the same time. It explained the phenomenon that glucocorticoids,
such as Dex, could greatly increase urinary excretion of water
without compensatory increases in water drinking in rats on ad
libitum water and food at a short period, leading to dramatic
volume depletion. The inhibitory effect of glucocorticoids on water
intake increases with time, leading to progressive systemic volume
depletion. Systemic volume depletion, in turn, compromises the
ability of the kidney to excrete water and sodium. Nevertheless, the
cumulative effects of chronic glucocorticoid treatment on water
and sodium intake produce a negative balance of both substances
[11]. This postulation is supported by the findings that central
inhibition of endogenous ANP in the brain could increase
spontaneous water intake, resulting in a dramatic increase in
diuresis [21].
Because rats drink when they eat and eat when they drink,
restriction of water or food effectively restricts consumption of
both. It is well established that high doses of Dex inhibit food
intake starting on the second day of treatment, that is,
approximately 24 hours after Dex administration [22,23]. Our
study revealed a new aspect of glucocorticoids as a molecule
regulating water intake. Thus, the inhibition of water intake may
be part of a larger, or more general, phenomenon and may not be
specific to water intake. Newly emerged evidence showed that
ANP also played a role in modulating feeding activity patterns in
rats [24]. A study by Tarjan showed intracerebral administration
ANP not only inhibited water and salt intake, but reduced food
intake, suggesting ANP may centrally inhibit food intake [25].
Further analyses on precise physiological implication of hypotha-
lamic NPR-A activation between food intake and body fluid
metabolism would lead to the better understanding of the
significance of the natriuretic peptide system in water intake and
food intake.
There is a widespread assumption that cortisol raises blood
pressure as a consequence of renal water and sodium retention
[26]. Given the fact glucocorticoids have potent volume-depleting
effect, what are the mechanisms underlying glucocorticoid-
induced hypertension? Previous researches found glucocorticoid-
induced hypertension involves the endothelial nitric oxide system,
which includes inhibition of inducible nitric oxide synthases and
endothelial nitric oxide synthases isoforms, and inhibition of
transmembrane arginine transport [27,28,29]. Furthermore, the
natural ligand cortisol has plenty of mineralocorticoid activity,
while the synthetic such as Dex is exclusively glucocorticoid in its
effects. Therefore, the blood pressure response to glucocorticoids is
more likely part of an overall mechanism to maintain hemody-
namic homeostasis in the face of volume depletion.
Collectively, the data presented here, coupled with the ability of
glucocorticoids to produce potent diuretic action in the fluid
retention status [9,30,31,32,33], suggested that glucocorticoids
played a central role in fluid volume control not only by
Figure 5. The effect of Dex pretreatment on plasma ANP and hypothalamic ANP content in the water-deprived rats. [A] Effect of 6-
hour Dex pretreatment on plasma ANP levels in water-deprived rats; *,0.01 compared with rats treated with vehicle; # ,0.01 compared with rats
treated with low dose of Dex. [B] Effect of 24-hour Dex pretreatment on plasma ANP levels in water-deprived rats; *,0.01 compared with rats treated
with vehicle; # ,0.01 compared with rats treated with low dose of Dex. [C] Effect of 24-hour Dex pretreatment on hypothalamic ANP contents in
water-deprived rats; n=10 for each group.
doi:10.1371/journal.pone.0015607.g005
Figure 4. The effect of Dex on hypothalamic NPR-A expression and cGMP content in the water-deprived rats. [A], [B] Effect of Dex
pretreatment on hypothalamic NPR-A expression in the water-deprived rats. [C] Effect of Dex on hypothalamic cGMP content in the water-deprived
rats. n=8 for each group. *,0.05 compared with vehicle. [D], [E] NPR-A positive neurons visualized by immunofluorescence in the hypothalamus
(white arrows denote increased NPR-A positive neurons) in the water-deprived rats. Abbreviations: RCh, retrochiasmatic nucleus; sox, Supraoptic
decussation; 3V, third ventricle. [F] Schematic drawing of a coronal section of the rat brain (from ref. [37]) at the level shown in [D] and [E]. The area
defined by the square is shown in [D] and [E].
doi:10.1371/journal.pone.0015607.g004
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natriuretic peptide system in the kidney, but also by blocking the
neurogenic mechanisms responsible for the stimulation of water
intake.
Methods
Ethics Statement
All animals were managed in accordance with the guidelines of
Hebei Medical University, and the position of the American Heart
Association on Research Animal Use. Experimental protocols
were approved by the Institutional Animal Care and Use
Committee of Hebei Medical University (approval ID: HebMU
20080301).
Animal protocol
Male Wistar rats (provided by Hebei Medical University)
weighing 220–250 g were housed in a temperature-controlled
environment, exposed to a 12:12-hour light-dark cycle, and given
ad libitum access to a commercial standard diet of rat chow and
Figure 6. Reversal of the effects of Dex on body fluid metabolism by RU486 in the water-deprived rats. [A] RU486 reversed the effect of
Dex on urinary volume in the water-deprived rats. #,0.01 compared with rats treated with vehicle. [B] RU486 reversed the effect of Dex on water
intake over 12-hour water-access period in the dehydrated rats; n=10 for each group; data were analyzed by two-way repeated measures ANOVA;
# ,0.01 compared with rats treated with vehicle. [C], [D], [E] RU486 reversed the effect of Dex on hypothalamic NPR-A expression and cGMP
production in the water-deprived rats; n=8 for each group; *,0.05 compared with rats treated with vehicle; # ,0.01 compared with rats treated
with vehicle. [F] Rabbit anit-hANP antiserum blocked the inhibitory effects of Dex on water intake in water-deprived rats; n=5–6 in each group;
vehicle = normal rabbit serum; data were analyzed by two-way repeated measures ANOVA; # ,0.01 compared with rats treated with vehicle.
doi:10.1371/journal.pone.0015607.g006
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week to adapt to the environment before initiation of the study
protocols.
Western blotting analysis
The hypothalamuses were dissected out following a previous
method. Briefly, the brains were placed ventral side up, and 4-
mm-thick coronal slices were cut caudal to the optic chiasm. The
slices were then dissected laterally up to the hypothalamic sulci
and dorsally up to the mammilothalamic tract. Western blotting
measurements were performed using the method previously
prescribed [34]. NPR-A antibody (ab70848) was provided by
Abcam Inc. Protein bands were digitally analyzed with Quantity
One 1-D Analysis Software (Bio-Rad). The densities were
expressed as a relative value compared with the average density
measured in the vehicle treated rats. Data were normalized to b-
actin for the individual animals.
Surgical procedure
The detailed procedure of intracerebroventricular (ICV) guide
cannula was prescribed before[35]. In brief, rats were fitted with
an ICV guide cannula that was stereotaxically implanted to
terminate in the third ventricle and fixed to the skull with dental
acrylic and three stainless-steel screws. The following stereotaxic
coordinates were used: 1.0 mm posterior to bregma, 1.0 mm
lateral to the sinus and angled toward the midline at 10, and
7.5 mm ventral from the dura. One week of recovery was allowed
for daily food and fluid intake, as well as body weight, to return to
pre-surgery levels before tests were initiated.
Analysis of plasma ANP
Plasma ANP was measured by radioimmunoassay. Blood
samples were collected into chilled plastic tubes containing EDTA
(1.5 mg/ml) and aprotinin (500 KIU/ml). Blood samples were
centrifuged at 4uC, and the plasma samples were separated and
stored at 270uC until assayed using radioimmunoassay. One
milliliter of plasma was extracted on a Cl8 SEP Pak column. The
cartridges were prewashed with 10 ml of methanol and 10 ml of
4% acetic acid. After the plasma was applied, the cartridges were
washed three times with 5 ml 0.1% vol/vol trifluoroacetic acid
and the absorbed peptide was eluted with 2 ml 60% actronitrile/
0.1% trifluoroacetic acid into plastic tubes. The extracts were
dried down and reconstituted in 1.0 ml buffer and measured by
radioimmunoassay Kit (provided by Neurobiology Department of
The Second Military Medical University).
Hypothalamic ANP content
After decapitation and blood collection from the trunk as
described above, the hypothalamic tissues were quickly removed
and boiled for 5 min in 10 volumes of 0.1 M acetic acid to abolish
intrinsic proteolytic activity and then homogenized with a polytron
homogenizer. The homogenates were centrifuged at 4000 rpm at
Figure 7. Potent volume depleting effect by Dex in rats given ad libitum access to food and water. [A] Effect of Dex on cumulative
urinary volume; n=10 for each group; * ,0.01 compared with rats treated with vehicle; # ,0.01 compared with rats treated with low dose of Dex.
[B] Effect of Dex on cumulative urinary sodium; * ,0.01 compared with rats treated with vehicle; # ,0.01 compared with rats treated with low dose
of Dex. [C] Effect of Dex on cumulative water intake. [D] Effect of Dex on food intake. [E] Effect of Dex on change from baseline in body weight;
* ,0.01 compared with rats treated with vehicle; # ,0.01 compared with rats treated with low dose of Dex.
doi:10.1371/journal.pone.0015607.g007
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220uC until assayed for ANP. Each sample was reconstituted with
1 ml of ANP buffer. Tissue ANP was expressed as per
hypothalamus.
Immunofluorescence. Hypothalamic NPR-A expression
was visualized by the indirect immunohistofluorescence method
of Coons and coworkers[36]. Wistar rats were perfused through
the heart first for 10 sec with ice-cold normal saline and then for
5–10 min with ice-cold phosphate-buffered 4% depolymerized
paraformaldehyde solution. Brains were postfixed for 90 min in
this perfusate and then soaked for at least 24 hours in 7% sucrose/
0.6 M phosphate buffer, pH 7.4. Cryostat sections (14 mm thick)
of hypothalamic region containing the median eminence were
processed for the indirect immunofluorescence technique. Sections
were stained at 37uC for 30 min with primary antibody (ab14356,
Abcam Inc) diluted 1:30 with phosphate-buffered saline containing
0.2% Triton X-100. The sections were then incubated for 18–
24 hours at 4uC with the primary antibody. After three 5-min
washes with phosphate-buffered saline/0.05% Triton, the sections
were exposed for 3 hours at 37uC to fluorescein-conjugated guinea
goat antibody against rabbit IgG (Goldenbridge biotechnology co.,
ltd) diluted 1:50 with phosphate-buffered saline/0.1% Triton. The
sections were then washed three times (5 min each) in phosphate-
buffered saline/0.2% Triton, dipped in H2O, and mounted with
0.5 M sodium bicarbonate buffer (pH 8.4) diluted with an equal
volume of glycerol. Each section was examined under darkfield
conditions with a Nikon ECLIPSE 80i fluorescence microscope.
Hypothalamic cGMP measurement
Hypothalamic tissues were homogenated in 1 ml Tris
(0.05 mol/L) +4 mmol/L EDTA at 4uC, and the homogenates
were heated for 3 min in a boiling water bath to coagulate
proteins. After 20-min centrifugation at 4,000 rpm at 4uC, the
supernatants were then assayed using cGMP radioimmunoassay
kit provided by Shanghai University of T.C.M.
Statistical analyses
All the data were express as means 6 standard error of mean
(s.e.m). Data in water intakes from the dehydration studies were
analyzed by two-way repeated measures ANOVA, followed by a
Student-Newman-Keuls test for multiple comparisons. Other
statistical calculations were performed using a standard t-test of
variables with 95% confidence intervals, unless otherwise stated.
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